(GNOV) FT Cboe Vest U.S. Equity - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740U6872

GNOV: FLEX Options, S&P 500

The FT Cboe Vest U.S. Equity Moderate Buffer ETF - November (GNOV) is an exchange-traded fund that employs a buffering strategy to manage risk. Under normal market conditions, it invests substantially all of its assets in FLexible EXchange (FLEX) Options that track the price performance of the SPDR S&P 500 ETF Trust, allowing for customization of key contract terms such as exercise prices, styles, and expiration dates.

As a non-diversified fund, GNOVs investment strategy is focused on a specific index, making its performance closely tied to the S&P 500. The use of FLEX Options enables the fund to offer a moderate buffer against losses, making it an attractive option for investors seeking to mitigate potential downsides while still participating in the potential upside of the S&P 500.

Analyzing the funds technical data, we observe that the last price is $35.11, with short-term and long-term moving averages (SMA20 and SMA50) indicating a positive trend. The Average True Range (ATR) of 0.72, representing 2.05% of the last price, suggests moderate volatility. Given the current price is near the 52-week high of $35.84, we can anticipate potential resistance at this level. Using the SMA20 and SMA50 as support levels, a potential buy signal is generated when the short-term average crosses above the long-term average, indicating a bullish trend.

Combining technical and fundamental analysis, we note that the funds Assets Under Management (AUM) stand at $255.45M USD, indicating a reasonable scale for an ETF in this category. With the S&P 500 being a broad market index, the funds performance will be influenced by overall market conditions. Given the current technical indicators and the moderate buffer strategy, our forecast suggests that GNOV may continue to track the S&P 500s performance with a reduced downside risk. If the S&P 500 experiences a moderate upswing, GNOV is likely to follow suit, potentially reaching $36.00 in the near term, while its buffer strategy may help limit losses in case of a downturn.

Additional Sources for GNOV ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

GNOV ETF Overview

Market Cap in USD 441m
Category Defined Outcome
TER 0.85%
IPO / Inception 2023-11-17

GNOV ETF Ratings

Growth Rating 46.6
Fundamental -
Dividend Rating 0.0
Rel. Strength -5.93
Analysts -
Fair Price Momentum 33.86 USD
Fair Price DCF -

GNOV Dividends

Currently no dividends paid

GNOV Growth Ratios

Growth Correlation 3m 93.6%
Growth Correlation 12m 53.1%
Growth Correlation 5y 86.1%
CAGR 5y 11.09%
CAGR/Max DD 5y 1.04
Sharpe Ratio 12m 0.84
Alpha -0.46
Beta 0.398
Volatility 5.23%
Current Volume 9.6k
Average Volume 20d 5.3k
What is the price of GNOV shares?
As of July 01, 2025, the stock is trading at USD 36.48 with a total of 9,588 shares traded.
Over the past week, the price has changed by +1.73%, over one month by +2.79%, over three months by +6.38% and over the past year by +7.90%.
Is FT Cboe Vest U.S. Equity a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, FT Cboe Vest U.S. Equity (BATS:GNOV) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 46.56 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GNOV is around 33.86 USD . This means that GNOV is currently overvalued and has a potential downside of -7.18%.
Is GNOV a buy, sell or hold?
FT Cboe Vest U.S. Equity has no consensus analysts rating.
What are the forecasts for GNOV share price target?
According to our own proprietary Forecast Model, GNOV FT Cboe Vest U.S. Equity will be worth about 37.7 in July 2026. The stock is currently trading at 36.48. This means that the stock has a potential upside of +3.29%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 37.7 3.3%